Nanologica AB (publ) (STO:NICA)

Market Cap	213.70M +96.6%
Revenue (ttm)	109.18M +45.3%
Net Income	24.07M
EPS	0.26
Shares Out	328.77M
PE Ratio	2.50
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,252,525
Average Volume	8,511,173
Open	0.6600
Previous Close	0.6500
Day's Range	0.6600 - 0.8640
52-Week Range	0.3300 - 2.2500
Beta	-0.12
RSI	56.52
Earnings Date	Apr 24, 2026

About Nanologica AB

Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and pu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 19
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NICA

Financial Performance

In 2025, Nanologica AB's revenue was 21.13 million, an increase of 45.32% compared to the previous year's 14.54 million. Losses were -51.29 million, -21.85% less than in 2024.